Mercer Global Advisors Inc Teva Pharmaceutical Industries LTD Transaction History

Mercer Global Advisors Inc

$43 Billion
Q1 2025

A detailed history of Mercer Global Advisors Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Mercer Global Advisors Inc holds 78,622 shares of TEVA stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,622

Previous 84,480 6.93%

Holding current value

$1.35 Million

Previous $1.86 Million 35.09%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$14.67 - $22.01 $85,936 - $128,934	-5,858 Reduced 6.93%	78,622 $1.21 Million
Q4 2024 Feb 14, 2025	SELL	$16.43 - $22.77 $127,431 - $176,604	-7,756 Reduced 8.41%	84,480 $1.86 Million
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $85,421 - $102,440	-5,403 Reduced 5.53%	92,236 $1.66 Million
Q2 2024 Aug 12, 2024	SELL	$12.78 - $17.4 $3,220 - $4,384	-252 Reduced 0.26%	97,639 $1.59 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $280,546 - $379,407	26,293 Added 36.72%	97,891 $1.38 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $389 - $510	-48 Reduced 0.07%	71,598 $747,000
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $1,092 - $1,562	-146 Reduced 0.2%	71,646 $731,000
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $800,388 - $1.05 Million	-111,165 Reduced 60.76%	71,792 $540,000
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $13,559 - $18,442	1,622 Added 0.89%	182,957 $1.62 Million
Q4 2022 Feb 08, 2023	SELL	$7.95 - $9.48 $721,033 - $859,798	-90,696 Reduced 33.34%	181,335 $1.65 Million
Q3 2022 Nov 15, 2022	BUY	$6.86 - $11.95 $1.24 Million - $2.17 Million	181,369 Added 200.05%	272,031 $2.2 Million
Q2 2022 Aug 10, 2022	BUY	$7.38 - $10.4 $403,626 - $568,796	54,692 Added 152.05%	90,662 $682,000
Q1 2022 May 10, 2022	SELL	$7.33 - $9.39 $33,380 - $42,762	-4,554 Reduced 11.24%	35,970 $338,000
Q4 2021 Feb 04, 2022	BUY	$7.9 - $10.19 $36,166 - $46,649	4,578 Added 12.74%	40,524 $325,000
Q3 2021 Nov 10, 2021	SELL	$8.38 - $10.18 $74,255 - $90,204	-8,861 Reduced 19.78%	35,946 $350,000
Q2 2021 Aug 10, 2021	BUY	$9.9 - $11.56 $32,769 - $38,263	3,310 Added 7.98%	44,807 $444,000
Q1 2021 May 11, 2021	SELL	$10.34 - $12.81 $388,546 - $481,361	-37,577 Reduced 47.52%	41,497 $479,000
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $4,787 - $6,138	556 Added 0.71%	79,074 $763,000
Q3 2020 Dec 10, 2020	BUY	$8.57 - $12.69 $487,110 - $721,286	56,839 Added 262.18%	78,518 $707,000
Q2 2020 Aug 10, 2020	BUY	$8.12 - $13.12 $17,368 - $28,063	2,139 Added 10.95%	21,679 $267,000
Q1 2020 May 18, 2020	BUY	$6.69 - $13.45 $130,722 - $262,813	19,540 New	19,540 $175,000

Others Institutions Holding TEVA

# of Institutions

660

Shares Held

626M

Call Options Held

27.9M

Put Options Held

21.8M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Teva Pharmaceutical Industries LTD Transaction History